The FDA wants to end bulk production of copycat versions of weight loss drugs; telehealth companies and compounding ...

Analysts, who are highly bullish on the stock, have fretted for some time that Viking needed a partner to actually make the ...

Viking Therapeutics has inked a $150m multi-year manufacturing deal with CordenPharma to secure the future supply of its ...

There are plenty of reasons to consider coming off the pill, from wanting to conceive to trying to get back in touch with your regular rhythms. But beware the people online who demonise hormonal ...

They come in different ratios, or combinations, of active and inactive ingredients. The combination pill is more than 99 percent effective when taken as intended. The most common type of ...

The case, called Missouri et al. v. FDA, is a revamped version of a lawsuit filed by anti-abortion groups and doctors in 2023 seeking to block the Food and Drug Administration’s (FDA ...

Oral chemotherapy kills or weakens cancer cells. It comes in the form of a pill, liquid, or tablet that a person swallows or places under the tongue to dissolve. It is not suitable for all stages ...

If passed, the EPIC Act would remove the so-called “pill penalty,” which poses a strong disincentive against developing small-molecule drugs, Thomas Kaiser, co-founder and chief scientific officer at ...

The NSW Government has announced that it will implement a twelve-month pill testing trial for music festivals in the state. They will be starting with the 2025 Yours & Owls Festival with the aim of ...

Since the Supreme Court eliminated the constitutional right to abortion in the 2022 case of Dobbs v. Jackson Women’s ... to limit access to the abortion pill. But he refused to rule out the ...

Or it could be an underlying condition like hypothyroidism. “It’s common not to get a period after stopping the pill,” explained Gil A. Weiss, MD, assistant professor of clinical medicine at ...

The Inflation Reduction Act targets small molecules for government price setting years earlier than other medicines, sending the wrong message to everyone trying to develop new breakthrough treatments ...